Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization

被引:24
作者
Leever, JD [1 ]
Clark, S [1 ]
Weeks, AM [1 ]
Partin, KM [1 ]
机构
[1] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA
关键词
D O I
10.1124/mol.64.1.5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid subtype of ionotropic glutamate receptors consists of rapidly gating ion channels. Positive modulation of channel gating may slow gating kinetics through at least two distinct mechanisms, evidenced by the predominant slowing of either the rate of receptor desensitization or the rate of offset after agonist withdrawal ( deactivation). This study compares the actions of two positive allosteric modulators [ cyclothiazide, which modulates desensitization, and 1-(1,4-benzodioxan-6-ylcarbonyl) piperidine (CX546), which modulates deactivation] in a mutant shown previously to impede modulation by cyclothiazide. These experiments test the hypothesis that the point mutation, GluR1(S493T), would also cause a loss of modulation by CX546. Wild-type GluR1 through -4 receptors were modulated by CX546, as assayed by the potentiation of steady-state currents in the Xenopus laevis oocyte expression system. CX546 potentiated steady-state currents of both splice isoforms of GluR1. Modulation by CX546 was completely abolished in GluR1( S493T) and its homolog, GluR2(S497T), although this mutation did not affect apparent agonist affinity in the absence of CX546. Thus, the GluR1( S493T) mutation has a similar impairment of modulation by either cyclothiazide or CX546, indicating that some residues at the subunit interface of glutamate receptors play an important role in channel deactivation and desensitization.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 27 条
[1]  
[Anonymous], J PHYSL
[2]  
Arai A, 1996, J PHARMACOL EXP THER, V278, P627
[3]   Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics [J].
Arai, A ;
Kessler, M ;
AmbrosIngerson, J ;
Quan, A ;
Yigiter, E ;
Rogers, G ;
Lynch, G .
NEUROSCIENCE, 1996, 75 (02) :573-585
[4]   Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: Interactions with cyclothiazide and GYKI 52466 [J].
Arai, AC ;
Kessler, M ;
Rogers, G ;
Lynch, G .
MOLECULAR PHARMACOLOGY, 2000, 58 (04) :802-813
[5]   Effects of 5′-alkyl-benzothiadiazides on (R,S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor biophysics and synaptic responses [J].
Arai, AC ;
Xia, YF ;
Kessler, M ;
Phillips, D ;
Chamberlin, R ;
Granger, R ;
Lynch, G .
MOLECULAR PHARMACOLOGY, 2002, 62 (03) :566-577
[6]   Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action [J].
Arai, AC ;
Xia, YF ;
Rogers, G ;
Lynch, G ;
Kessler, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) :1075-1085
[7]   Structure of a glutamate-receptor ligand-binding core in complex with kainate [J].
Armstrong, N ;
Sun, Y ;
Chen, GQ ;
Gouaux, E .
NATURE, 1998, 395 (6705) :913-917
[8]  
Creighton TE, 1993, PROTEINS STRUCTURES
[9]  
Dingledine R, 1999, PHARMACOL REV, V51, P7
[10]   A DRUG THAT FACILITATES GLUTAMATERGIC TRANSMISSION REDUCES EXPLORATORY ACTIVITY AND IMPROVES PERFORMANCE IN A LEARNING-DEPENDENT TASK [J].
GRANGER, R ;
STAUBLI, U ;
DAVIS, M ;
PEREZ, Y ;
NILSSON, L ;
ROGERS, GA ;
LYNCH, G .
SYNAPSE, 1993, 15 (04) :326-329